1. Build a Strong Employer BrandFirst up, let’s talk about your employer brand. Think of it as your company’s personality and reputation. In Japan’s competitive pharmaceutical and medical device industry, it’s crucial to stand out. You need to showcase your…
HOME > ORGANIZATION
ORGANIZATION
- JPA Expresses Deep Regrets over Court Ruling on Online Sale of OTC Drugs
January 16, 2013
- JMA Vice Pres. Nakagawa Urges Pharmacies to Rigidly Check Medical Exam History of Epadel OTC Buyers
January 15, 2013
- JMA Sets Up “Council on Medical COI” Out of Concerns Over Transparency GL
January 11, 2013
- JPWA Chief Bessho Calls for Clearer Rule for Sales Tax on Ethical Drugs
January 10, 2013
- Efforts to Promote Generic Substitution Preferable to Cutting Prices of Long-Listed Drugs: Mr Sawai of JGA
January 8, 2013
- Member Companies to Begin Enforcing New COP in FY2013: JPMA President Teshirogi
January 7, 2013
- JPMA to Ask Abe Administration to Continue Former Dialogue with Pharmaceutical Industry: Dr Teshirogi
January 7, 2013
- NHO to Review Calculation Method for Clinical Trial Costs
December 28, 2012
- JPA to Hold Workshops to Train Pharmacists to Make Clinical Assessments Based on Subjective Symptoms
December 26, 2012
- JMA to Discuss JPMA’s Transparency Guidelines with JPMA, Related Medical Organizations
December 25, 2012
- “New Administration Needed to Allocate Personnel to Cabinet, LDP to Work Out Challenges”: Keizai Doyukai Chair Hasegawa
December 19, 2012
- Generic Market Share at 25.4% in 2nd Quarter on Volume Basis: JGA
December 14, 2012
- Tohoku Pharmaceutical Univ. to Acquire Tohoku Kosei Nenkin Hospital, Aiming to Turn It into Model Hospital for Pharmaceutical Education
December 14, 2012
- Panelists at IGPA Conference Express Concern that FTA Could Strengthen Intellectual Property Rights
December 10, 2012
- GIST Patients Group Submits Petition Calling for Early Filing for Regorafenib for GIST
December 10, 2012
- Kyoto Declaration Calls for Strict Quality Control of Generics: IGPA Annual Conference
December 10, 2012
- Biosimilars Popular Topic at IGPA Annual Conference
December 10, 2012
- Ways to Deal with Biosimilars Will Be Common Challenge Among Generics Companies: JGA President Sawai
December 6, 2012
- Drug Costs Should Be Basically Borne by Patients under Compassionate Use System: JPMA’s Kuwahara
December 5, 2012
- 80 Medical Institutions Submit Comprehensive Agreements on Info Disclosure in Response to JPMA Transparency GLs
December 4, 2012
ページ
In late January, a bill to amend the Pharmaceuticals and Medical Devices Act cleared key legislation review processes by the…
A Japanese health ministry panel on December 26 wrapped up its discussions on the next amendment of the Pharmaceuticals and…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s key reimbursement policy panel on December 25 approved an outline of the FY2025 drug price revision, finalizing plans to…
For the first time in many years, Japan appeared to have pivoted to a pro-innovation path with the FY2024 drug pricing reform. All eyes were apparently on this course change as seen in this year’s most-read story list, though the…
A Japanese health ministry panel discussing the generic industry structure on May 22 put together a report in which it…
A Japanese health ministry study group focused on pharmaceutical regulations on March 21 agreed on a policy to encourage the…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…
The Japanese health ministry’s expert panel tasked to discuss comprehensive policies for the rapid and stable supply of pharmaceuticals generally…